Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
41/100
Pipeline Velocity
15/100
Trial Completion Rate
N/A
Pipeline Concentration
100/100
Pipeline Freshness
90/100
Activity
Last 14 days
SEquential Treatment of PSoriasis With Biologics
Evidence Based, Patient-led Development of a Novel Axial Spondyloarthritis Flare Management Pathway
A Trial of the Difference in Staff Time Involved in Repositioning Proned Patients in the ICU Using the 'BathMat' Compared With Standard Care
Improving Pulmonary Hypertension Screening by Echocardiography
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)